This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Other and unspecified vaccines and biological substances
VWXY20_OTHER_UNSPE_VACCINES_BIOLO_SUBST
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
236 |
4. Check minimum number of eventsNone |
236 |
5. Include endpointsNone |
236 |
6. Filter based on genotype QC (FinnGen only) |
236 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Y[4-5]
Similar endpoints
↥List of similar endpoints to
Other and unspecified vaccines and biological substances
based on the number of shared cases.
Similar with more cases:
- Drugs, medicaments and biological substances causing adverse effects in therapeutic use
- Complications of medical and surgical care
- External causes of morbidity and mortality
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 236 | 179 | 57 |
| Unadjusted period prevalence (%) | 0.05 | 0.06 | 0.03 |
| Median age at first event (years) | 46.03 | 45.46 | 47.83 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 214
- Matched controls
- 2140
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Y59
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified vaccines and biological substances
4503599627370496.0
291.1
213
9
T78.4
ICD-10 Finland
Allergy, unspecified
25.4
54.7
79
48
C01CA24
ATC
epinephrine; parenteral
16.2
47.4
82
79
T78.2
ICD-10 Finland
Anaphylactic shock, unspecified
114.9
36.0
38
*
T88.6
ICD-10 Finland
Anaphylactic shock due to adverse effect of correct drug or medicament properly administered
+∞
27.7
26
*
XQ800
NOMESCO Finland
Prick test
8.0
25.9
64
108
H02AB06
ATC
prednisolone; systemic
4.6
24.8
141
628
T78.3
ICD-10 Finland
Angioneurotic oedema
32.0
17.8
23
8
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
5.5
17.8
58
136
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
20.6
16.4
24
13
R03AC02
ATC
salbutamol; inhalant
3.2
14.3
146
863
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.2
14.0
103
484
J45.9
ICD-10 Finland
Asthma, unspecified
3.8
13.5
65
220
T78.0
ICD-10 Finland
Anaphylactic shock due to adverse food reaction
+∞
12.6
12
*
R03DC03
ATC
montelukast; oral
3.6
12.1
63
222
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
3.6
12.1
63
222
X59
ICD-10 Finland
Exposure to unspecified factor
3.4
11.1
60
219
J45.0
ICD-10 Finland
Predominantly allergic asthma
4.2
10.6
42
118
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
6.6
10.2
26
44
X58
ICD-10 Finland
Exposure to other specified factors
3.6
10.1
48
158
R4110
NOMESCO Finland
Physiotherapy
2.8
9.9
76
347
T88.1
ICD-10 Finland
Other complications following immunization, not elsewhere classified
+∞
9.4
9
*
J46
ICD-10 Finland
Status asthmaticus
9.7
9.2
18
20
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.5
9.1
101
567
R06AX13
ATC
loratadine; oral
3.0
8.9
56
223
L50.9
ICD-10 Finland
Urticaria, unspecified
6.3
8.9
23
40
R06AE07
ATC
cetirizine; oral
2.4
8.8
115
697
R50.9
ICD-10 Finland
Fever, unspecified
3.5
8.8
43
144
A92
ICPC
Allergy/allergic reaction NOS
6.9
8.7
21
33
R03AK06
ATC
salmeterol and fluticasone; inhalant
3.8
8.7
38
116
WX892
NOMESCO Finland
Monitored bed care
5.1
8.7
27
59
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
3.2
8.6
48
177
X49
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances
28.8
8.6
11
*
J30.10
ICD-10 Finland
Allergic rhinitis due to pollen
4.6
8.4
29
71
H02AB07
ATC
prednisone; oral
3.4
8.2
41
140
R06.0
ICD-10 Finland
Dyspnoea
2.7
7.6
60
272
R06AX27
ATC
desloratadine; oral
2.4
7.6
83
451
R42
ICD-10 Finland
Dizziness and giddiness
2.7
7.5
55
240
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.5
7.5
68
333
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.8
7.2
30
88
R03BA02
ATC
budesonide; inhalant
2.7
7.2
51
219
L50.0
ICD-10 Finland
Allergic urticaria
6.7
7.1
17
27
A02BA02
ATC
ranitidine; systemic
2.8
7.0
47
194
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
3.4
7.0
34
113
XF600
NOMESCO Finland
Bloodpressure measurement
4.5
7.0
24
59
R03BB04
ATC
tiotropium bromide; inhalant
4.2
6.8
25
66
UDQ12
NOMESCO Finland
Flexible laryngoscopy
5.1
6.7
20
42
S01GX01
ATC
cromoglicic acid; ophthalmic
2.5
6.7
60
292
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.1
6.7
37
134
WX408
NOMESCO Finland
General anesthesy, balanced
2.4
6.7
67
343
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
3.5
6.7
31
100
E000001
ATC
NA
2.5
6.6
61
299
WVA40
NOMESCO Finland
Initiation and monitoring of intravenous hydration
14.9
6.5
10
7
TDM10
NOMESCO Finland
Puncture of maxillary antrum
5.7
6.3
17
32
NG1BG
NOMESCO Finland
Knee and lower leg MRI examination with high intensity magnet
5.0
6.3
19
41
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
27.6
6.3
8
*
N02AX02
ATC
tramadol; systemic, rectal
2.1
6.3
85
503
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
4.1
6.2
23
61
EP1AE
NOMESCO Finland
Neck ultrasound examination
4.3
6.2
22
56
XF400
NOMESCO Finland
ECG with 12 standard connections
2.9
6.2
39
155
N17
ICPC
Vertigo/dizziness
3.1
6.1
34
124
J01FF01
ATC
clindamycin; systemic
2.2
6.0
69
376
A02BC05
ATC
esomeprazole; systemic
2.1
6.0
89
543
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.5
6.0
49
226
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
73
297
3.11
13.49
4.4
2.9
191.4
183.8
ng/l
0.02
45
189
12
13
9.67
9.95
1.4
2.9
—
—
—
0
0
27
69
4.29
9.89
1.3
1.6
0.2
0.2
g/l
0.10
27
69
11
11
10.44
9.61
1.6
1.4
—
—
—
0
0
118
702
2.36
9.55
7.4
4.6
36.4
36.4
g/l
0.03
108
665
165
1146
2.46
9.22
13.9
8.9
3.9
4.0
e9/l
0.33
146
1007
109
641
2.30
8.90
1.9
1.8
105.6
97.5
pmol/l
0.72
64
331
22
52
4.56
8.87
4.5
2.7
—
—
—
0
0
82
431
2.38
8.64
4.0
1.8
1.1
1.0
mg/l
0.13
61
329
50
213
2.71
8.15
5.8
2.7
3.8
8.0
umol/l
1.76
45
182
115
717
2.18
7.88
7.3
6.1
1.2
1.2
mmol/l
0.17
109
661
33
115
3.17
7.69
2.3
1.4
—
—
—
0
0
124
805
2.14
7.57
8.5
6.9
1.2
1.2
mmol/l
0.13
114
676
71
371
2.31
7.44
1.5
1.4
20.3
22.5
nmol/l
0.52
62
323
44
186
2.68
7.24
2.3
1.7
—
—
—
0
0
21
57
3.95
7.09
1.2
1.2
0.9
0.9
u/ml
0.03
12
22
55
262
2.43
7.07
2.4
1.8
—
—
—
0
0
100
614
2.09
6.91
4.3
3.1
—
—
—
0
0
81
460
2.16
6.85
3.0
2.0
2.9
3.0
mg/l
0.13
71
405
34
131
2.86
6.65
3.6
4.6
1.3
2.0
mmol/l
0.78
27
95
56
277
2.34
6.59
3.3
2.8
3.6
3.3
e6/l
0.08
32
146
42
182
2.59
6.56
2.3
1.6
—
—
—
0
0
58
295
2.28
6.38
3.5
2.4
0.5
0.9
e6/l
1.14
34
162
40
172
2.60
6.34
2.5
2.2
30.5
29.5
u/l
0.09
31
137
16
39
4.33
6.19
16.4
5.5
369.4
847.3
iu/ml
—
5
6
39
171
2.53
5.93
11.1
4.3
243.1
253.0
u/l
0.14
39
163
10
9
11.53
5.85
1.4
3.4
1481.5
713.1
u/ml
—
10
9
22
72
3.27
5.66
1.9
1.4
—
—
—
0
0
181
1436
2.12
5.63
5.1
3.8
12.2
9.8
mm/h
1.47
174
1325
15
39
4.04
5.35
1.7
1.4
—
—
—
0
0
15
39
4.04
5.35
1.7
1.4
—
—
—
0
0
11
22
5.20
5.31
1.3
1.1
—
—
—
0
0
11
22
5.20
5.31
1.3
1.1
—
—
—
0
0
11
22
5.20
5.31
1.3
1.1
—
—
—
0
0
138
1012
1.88
5.23
4.4
2.9
110.1
75.7
ug/l
0.48
132
950
5
0
+∞
5.22
1.0
0.0
—
—
—
0
0
140
1032
1.88
5.21
6.6
4.4
6.6
6.4
mmol/l
0.55
126
937
80
496
1.93
5.08
4.4
2.8
0.2
0.3
e6/l
0.52
67
363
15
41
3.84
5.01
1.7
1.1
2.1
3.2
u/ml
—
8
14
112
777
1.84
4.99
2.8
2.4
76.4
75.3
nmol/l
0.16
102
714
70
423
1.93
4.76
4.4
2.6
323.9
8026.6
umol/l
2.24
63
375
14
38
3.85
4.72
1.7
1.2
1.8
1.2
u/ml
—
5
11
16
50
3.36
4.42
1.2
1.2
—
47.3
—
0
6
85
558
1.82
4.42
1.9
1.6
—
—
—
0
0
10
22
4.70
4.34
1.3
1.1
—
—
—
0
0
10
22
4.70
4.34
1.3
1.1
—
—
—
0
0
161
1278
1.82
4.34
6.6
4.2
381.2
2733.8
e6/l
—
6
22
7
6
11.97
4.30
1.9
3.0
187.7
108.7
%
—
7
6
16
51
3.29
4.29
1.1
1.0
1.4
2.4
e6/l
—
10
38
16
51
3.29
4.29
1.1
1.2
3.1
29.6
e6/l
1.04
11
41
125
930
1.73
4.15
11.2
5.5
10.9
11.6
umol/l
0.15
120
870
51
289
1.98
4.13
2.6
2.5
2.4
2.4
mmol/l
0.01
45
249
87
586
1.77
4.10
3.1
3.0
37.4
39.7
ng/l
0.03
45
321
11
28
4.07
4.02
1.6
1.4
—
—
—
0
0
70
445
1.81
3.99
3.2
2.1
—
—
—
0
0
14
43
3.40
3.97
1.2
1.1
—
—
—
0
0
222
1997
2.88
3.89
25.0
11.3
16.2
20.2
mg/l
1.69
196
1512
14
45
3.24
3.71
1.4
1.2
—
—
—
0
0
185
1565
1.84
3.67
5.2
3.7
—
—
—
0
0
28
134
2.24
3.51
6.3
6.2
1.3
1.2
mmol/l
0.19
28
126
19
76
2.63
3.47
1.1
1.4
—
—
—
0
0
20
84
2.51
3.33
1.8
1.7
—
—
—
0
0
83
582
1.66
3.25
3.3
3.0
2.4
2.4
mmol/l
0.06
73
525
8
16
5.13
3.08
1.3
1.0
—
—
—
0
0
78
545
1.64
3.07
1.5
1.3
1.5
1.8
u/ml
0.13
11
149
182
1566
1.71
3.00
5.5
4.2
14.5
14.5
pmol/l
0.02
173
1452
7
14
5.12
2.75
1.3
1.1
—
—
—
0
0
9
24
3.86
2.70
1.1
1.1
—
—
—
0
0
35
203
1.85
2.63
7.7
6.6
1.1
1.1
mmol/l
0.01
35
191
20
95
2.21
2.57
1.7
1.6
—
—
—
0
0
54
358
1.66
2.57
3.3
2.8
433.3
740.2
ng/l
2.05
47
288
9
26
3.56
2.51
1.1
1.1
—
—
—
0
0
118
944
1.50
2.44
4.9
4.1
—
—
—
0
0
9
27
3.42
2.42
1.1
1.1
—
—
—
0
0
9
28
3.30
2.33
1.1
1.1
—
—
—
0
0
54
371
1.59
2.21
1.4
1.3
14.2
27.9
iu/ml
1.43
12
128
199
1801
1.67
2.17
19.2
9.8
92.1
90.1
ml/min/173m2
0.61
181
1447
6
14
4.37
2.16
2.2
1.1
—
—
—
0
0
201
1828
1.67
2.10
6.5
4.9
1.7
1.8
mu/l
0.98
194
1709
14
63
2.30
2.05
1.3
1.4
—
—
—
0
0
10
38
2.70
2.03
1.1
1.1
—
—
—
0
0
5
11
4.62
1.95
1.4
1.0
—
—
%
—
0
0
31
191
1.72
1.93
1.2
1.3
182.0
146.4
iu/ml
0.17
17
77
40
265
1.61
1.90
1.7
1.6
1260.5
1212.1
nmol/l
0.09
30
205
9
34
2.71
1.88
2.0
1.5
—
—
—
0
0
5
12
4.23
1.83
1.0
1.1
—
—
—
0
0
27
163
1.74
1.81
1.8
2.4
35577.1
3572.2
u/l
—
7
75
157
1373
1.43
1.80
4.9
2.9
39.6
39.2
u/l
0.03
151
1306
63
469
1.47
1.77
1.8
1.7
1.4
1.4
mmol/l
0.09
55
399
17
89
1.98
1.75
2.2
3.3
0.2
0.1
e6/l
0.17
17
84
19
104
1.90
1.73
7.2
8.2
25.2
24.8
mmol/l
0.18
19
104
220
2073
1.90
1.72
16.5
8.8
27.4
24.8
u/l
1.48
215
2005
25
151
1.73
1.68
23.7
20.9
1.0
1.3
inr
—
6
24
6
19
3.21
1.67
1.3
1.1
—
—
—
0
0
12
56
2.20
1.64
1.6
1.3
—
—
—
0
0
5
14
3.62
1.62
2.6
3.6
25.8
23.6
umol/l
—
5
14
50
364
1.47
1.57
1.4
1.3
3.1
9.8
u/ml
1.71
12
157
19
108
1.83
1.56
1.5
1.3
179.1
310.5
miu/ml
—
10
53
10
44
2.33
1.55
1.5
1.8
—
—
—
0
0
11
51
2.21
1.53
2.9
1.7
—
—
—
0
0
182
1656
1.43
1.52
5.0
4.8
38.4
38.4
mmol/mol
0.02
173
1563
6
21
2.90
1.51
1.5
1.3
—
—
—
0
0
20
117
1.78
1.50
1.9
1.6
—
—
—
0
0
5
16
3.17
1.44
1.2
1.3
—
—
—
0
0
6
22
2.77
1.44
1.2
1.0
—
—
—
0
0
231
2240
2.47
1.42
33.4
17.2
133.1
134.6
g/l
0.89
231
2213
205
1916
1.53
1.41
27.7
12.2
40.0
40.0
%
0.04
167
1533
5
17
2.98
1.36
1.2
1.5
—
—
—
0
0
6
24
2.54
1.31
3.2
2.0
—
—
—
0
0
13
70
1.91
1.26
10.8
8.0
25.0
24.6
mmol/l
0.24
13
65
5
20
2.53
1.15
1.0
1.3
—
—
—
0
0
5
20
2.53
1.15
3.6
2.1
—
—
—
0
0
5
20
2.53
1.15
1.6
1.3
—
—
—
0
0
5
20
2.53
1.15
1.2
1.6
—
—
—
0
0
12
65
1.89
1.15
1.3
1.1
—
—
—
0
0
191
1784
1.37
1.10
4.2
3.8
5.8
5.7
mmol/l
0.17
181
1666
8
41
1.98
1.10
1.0
1.4
—
—
—
0
0
24
162
1.54
1.09
2.9
3.1
—
—
—
0
0
9
46
1.99
1.05
1.3
1.3
—
103.9
—
0
12
10
53
1.93
1.03
2.8
1.7
—
—
—
0
0
11
61
1.84
1.00
1.3
1.5
—
—
—
0
0
5
23
2.20
0.98
1.2
1.2
0.4
0.4
nmol/l
—
5
23
7
36
1.97
0.98
6.6
4.1
15.4
23.1
mg/l
—
7
30
7
36
1.97
0.98
6.4
4.1
81.7
39.2
mg/l
—
7
30
13
77
1.73
0.97
11.3
8.0
0.9
0.7
%
0.66
13
77
7
37
1.92
0.95
3.1
1.7
—
—
—
0
0
9
52
1.76
0.93
1.2
1.4
26.6
36.5
nmol/l
—
9
52
6
28
2.17
0.92
1.2
1.1
—
—
—
0
0
6
29
2.10
0.90
2.3
1.7
—
—
—
0
0
8
44
1.85
0.87
3.4
2.0
—
—
—
0
0
8
44
1.85
0.87
1.3
1.2
—
1.2
—
0
5
8
45
1.80
0.85
1.6
1.2
—
—
—
0
0
19
130
1.50
0.84
2.1
3.1
76.0
78.1
ml/min/173m2
—
9
51
11
66
1.70
0.80
3.4
2.5
1.4
1.2
%
0.38
11
66
6
34
1.78
0.77
3.0
1.4
—
—
—
0
0
7
38
1.87
0.74
2.6
1.7
—
—
—
0
0
6
110
0.53
0.74
1.7
1.8
—
—
—
0
0
5
25
2.02
0.73
1.2
1.1
—
—
—
0
0
49
406
1.26
0.70
3.3
4.1
30.1
51.5
mg/mmol
0.18
31
253
11
69
1.62
0.69
1.2
2.1
—
—
—
0
0
5
27
1.87
0.69
1.2
1.1
—
—
—
0
0
107
965
1.20
0.68
3.6
3.4
0.0
0.0
estimate
0.00
15
200
12
78
1.57
0.67
12.2
8.0
1.4
1.5
%
0.16
12
78
5
29
1.74
0.64
3.2
2.2
13.4
13.3
%
—
5
29
11
72
1.55
0.60
1.3
1.2
—
—
—
0
0
6
36
1.68
0.57
12.0
3.5
62.2
57.5
%
—
6
36
43
507
0.81
0.56
4.0
3.7
0.0
0.0
estimate
0.00
15
200
9
64
1.42
0.52
3.8
1.9
—
—
—
0
0
106
980
1.15
0.46
3.7
3.4
0.0
0.0
estimate
0.00
14
195
10
138
0.71
0.42
1.5
2.5
27.2
39.4
u/ml
—
10
131
7
103
0.67
0.40
3.0
1.5
—
—
—
0
0
8
61
1.32
0.40
2.8
1.9
—
—
—
0
0
104
971
1.13
0.37
5.5
4.7
0.0
0.0
estimate
0.00
15
204
6
44
1.37
0.34
1.2
1.1
—
—
—
0
0
13
166
0.77
0.34
1.4
1.5
—
—
—
0
0
70
761
0.89
0.34
3.8
3.3
—
—
—
0
0
32
277
1.18
0.33
2.1
1.9
—
—
—
0
0
22
260
0.83
0.31
1.4
1.5
—
—
—
0
0
25
214
1.19
0.29
1.9
1.8
—
—
—
0
0
8
64
1.26
0.28
4.6
5.3
64.4
45.5
%
—
8
64
18
214
0.83
0.27
2.4
4.0
25.8
22.9
%
—
7
101
51
466
1.12
0.26
3.0
2.2
—
—
—
0
0
193
1891
1.11
0.22
4.5
4.1
2.8
2.8
mmol/l
0.54
184
1779
10
123
0.80
0.21
1.3
1.6
—
—
—
0
0
0
13
0.00
0.21
0.0
2.4
—
16.8
—
0
8
6
49
1.23
0.20
1.0
1.2
—
—
—
0
0
8
72
1.11
0.16
1.4
1.2
—
—
—
0
0
16
182
0.87
0.16
9.9
6.0
—
—
—
0
0
12
102
1.19
0.15
1.3
1.4
—
—
—
0
0
53
500
1.08
0.15
1.5
1.5
—
—
—
0
0
8
97
0.82
0.14
1.4
2.2
—
—
—
0
0
184
1811
1.07
0.14
3.8
3.4
1.3
1.2
mmol/l
0.72
176
1698
17
152
1.13
0.12
1.2
1.5
—
—
—
0
0
44
422
1.05
0.08
3.1
2.0
—
—
—
0
0
15
142
1.06
0.02
1.2
1.4
—
—
—
0
0
15
142
1.06
0.02
1.2
1.4
—
—
—
0
0
15
142
1.06
0.02
1.2
1.4
—
—
—
0
0
15
143
1.05
0.01
1.2
1.4
—
—
—
0
0
22
227
0.97
0.01
1.9
1.6
—
—
—
0
0
14
138
1.02
0.00
2.2
1.4
—
—
—
0
0
187
1873
0.99
0.00
4.3
3.8
4.6
4.7
mmol/l
1.03
180
1769
187
1865
1.01
0.00
4.2
3.8
1.5
1.5
mmol/l
0.80
177
1756
14
145
0.96
0.00
1.1
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.4
—
12.1
—
0
9
6
59
1.02
0.00
1.0
1.1
1.8
3.1
ug/l
—
6
52
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: VWXY20_OTHER_UNSPE_VACCINES_BIOLO_SUBST – Other and unspecified vaccines and biological substances
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).